AMA Therapeutic Insights

A disease-specific CME newsletter with the latest treatment guidelines and unprecedented prescribing data views.

Current newsletters

Summer 2008
Gaining control of asthma in children 

Spring 2008
Management of osteoporosis in primary care

Winter 2007
Management of depression in primary care

Fall 2007
Current management of dyslipidemia

What does AMA Therapeutic Insights offer physicians?

• Up-to-date, disease-specific, state and national level prescribing data*
• Disease demographics, comorbidities, data on patients diagnosed and treated vs. diagnosed and not treated
• Best practices and evidence-based therapy guidelines presented in case-study format
• AMA PRA Category 1 Credit™
• Integrated views of actual treatment practices for the respective disease states
• A new disease-specific newsletter every quarter

*The AMA does not collect, compile, license, sell or have access to physician prescribing data. The prescribing data included in AMA Therapeutic Insights are provided by IMS Health and are HIPAA compliant and do not contain any patient identifiable information.

How does AMA Therapeutic Insights increase the transparency of physician prescribing data?
For the first time, physicians are given access to disease-specific prescribing data and other therapy-related information in a unique CME professional development activity. AMA Therapeutic Insights offers physicians a new opportunity to improve the quality of patient care through a greater understanding of prescribing and treatment information.

How is prescribing data used for the benefit of the public?
Prescribing data are utilized by public health agencies for a variety of purposes, including studies about drug interactions, prescribing trends, long-term effects of medications, and prevention of medical errors. Medical Researchers also use prescribing information for applications such as setting and promoting public policy, accelerating healthcare innovations, driving best clinical practice, monitoring drug safety, and clinical trial recruitment.

The AMA gives special recognition to the California Medical Association, Connecticut State Medical Society, and Michigan State Medical Society for their ground-breaking participation in the AMA Therapeutic Insights program.

AMA Continuing Medical Education (CME)
Online continuing medical education programs, printed monographs for CME, seminars, direct credit CME programs and information about the AMA's Physician Recognition Award and credit system.

AMA Therapeutic Insights has been certified for AMA PRA Category 1 Credit™. The program content will be developed in compliance with AMA Standards for Industry-Supported Multimedia Continuing Medical Education and Other Communications and the Accreditation Council for Continuing Education (ACCME) Essential Elements. The AMA is accredited by the ACCME to provide continuing medical education for physicians.

Principles for Web site privacy and confidentiality

If you need additional information, please contact us at tinsights@ama-assn.org or (800) 621-8335.